Michael Lefenfeld - 24 May 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
24 May 2021
Net transactions value
+$86,150
Form type
4
Filing time
26 May 2021, 21:32:21 UTC
Next filing
01 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $10,680 +600 +2.7% $17.80 22,822 24 May 2021 Direct
transaction IMNM Common Stock Purchase $50,065 +2,715 +12% $18.44 25,537 25 May 2021 Direct F1
transaction IMNM Common Stock Purchase $25,405 +1,335 +5.2% $19.03 26,872 26 May 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.38 to $18.52, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
F2 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.66 to $19.43, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.